Jacobson Pharma to redeem HK$220 million of convertibles on Aug. 30

By Sarah Lizee

Olympia, Wash., Aug. 28 – Jacobson Pharma Corp. Ltd. intends to redeem HK$220 million of convertible notes held by HH InRe JP, Ltd. on Aug. 30, according to a notice.

HH InRe agreed to terms of the redemption on Aug. 28.

The convertibles will be redeemed at par plus accrued interest to the redemption date of HK$1,286,849.32.

The convertibles were originally issued in 2017 for a principal amount of HK$500 million to two subscribers, including Dragons 615 Ltd., a wholly owned limited liability company of DCP China Credit Fund I, LP, and HH InRe, an indirectly wholly owned limited liability company of Hillhouse InRe Fund, LP.

Jacobson said it had redeemed the HK$280 million Dragon convertibles on July 31.

The pharmaceutical company is based in Hong Kong.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.